| LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214 |
21 |
| PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy |
18 |
| Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer |
16 |
| Circular RNAs and human glioma |
16 |
| Enterolactone modulates the ERK/NF-kappa B/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-beta-induced epithelial-mesenchymal transition |
13 |
| Advances in isolation and detection of circulating tumor cells based on microfluidics |
12 |
| Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210 |
11 |
| A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses |
10 |
| Aberrant expression of enzymes regulating m(6)A mRNA methylation: implication in cancer |
10 |
| Key questions about the checkpoint blockade-are microRNAs an answer? |
10 |
| Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis |
10 |
| Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China |
9 |
| Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer |
9 |
| Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 587 patients |
8 |
| Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences |
8 |
| Clinical significance of miRNA-106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy |
8 |
| Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study |
7 |
| The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? |
6 |
| Tissue specificity of DNA damage response and tumorigenesis |
6 |
| The PI3K/Akt/GSK-3 beta/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility |
6 |
| Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways |
6 |
| Flotillin1 promotes EMT of human small cell lung cancer via TGF-beta signaling pathway |
6 |
| Progress in non-invasive detection of liver fibrosis |
6 |
| The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis |
6 |
| Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients |
5 |
| Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment |
5 |
| Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer |
5 |
| Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis |
5 |
| Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy |
5 |
| Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology |
5 |
| Qidong: a crucible for studies on liver cancer etiology and prevention |
5 |
| New developments in immunotherapy for lymphoma |
5 |
| Knockdown of long non-coding RNA LCPAT1 inhibits autophagy in lung cancer |
5 |
| LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival |
5 |
| Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients |
4 |
| BRAF(v600E) vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules |
4 |
| STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression |
4 |
| Hepatitis B virus X protein enhances hepatocarcinogenesis by depressing the targeting of NUSAP1 mRNA by miR-18b |
4 |
| The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy |
4 |
| Current applications and future prospects of nanotechnology in cancer immunotherapy |
4 |
| CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16(INK4a) |
4 |
| Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer |
4 |
| Modified Blumgart anastomosis without pancreatic duct-to-jejunum mucosa anastomosis for pancreatoduodenectomy: a feasible and safe novel technique |
4 |
| Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma |
4 |
| Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site |
4 |
| Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer |
4 |
| G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future |
4 |
| PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs |
4 |
| Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy |
4 |
| Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients |
4 |
